In study on gynecological malignancies, Xuan et al. (2022) reported that SCD1 is abnormally upregulated in ascites-derived ovarian cancer (OvCa) cells, and is closely associated with tumor invasiveness and chemoresistance. Here, SCD is linked to ovarian cancer.